| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 176.22 |
| Log P | RDKit | 1.37 |
| Topological polar surface area (Å2) | RDKit | 33.2 |
| Number of hydrogen bond acceptors | RDKit | 2 |
| Number of hydrogen bond donors | RDKit | 0 |
| Number of carbon atoms | RDKit | 10 |
| Number of heavy atoms | RDKit | 13 |
| Number of heteroatoms | RDKit | 3 |
| Number of nitrogen atoms | RDKit | 2 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 1 |
| Stereochemical complexity | RDKit | 0.1 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 6 |
| Number of sp3 hybridized carbon atoms | RDKit | 4 |
| Shape complexity | RDKit | 0.4 |
| Number of rotatable bonds | RDKit | 0 |
| Number of aliphatic carbocycles | RDKit | 0 |
| Number of aliphatic heterocycles | RDKit | 1 |
| Number of aliphatic rings | RDKit | 1 |
| Number of aromatic carbocycles | RDKit | 0 |
| Number of aromatic heterocycles | RDKit | 1 |
| Number of aromatic rings | RDKit | 1 |
| Total number of rings | RDKit | 2 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 1 |
| Number of saturated rings | RDKit | 1 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 2 |
| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 0 |
| Lipinski’s rule of 5 | RDKit | Passed |
| Number of Ghose rule violations | RDKit | 0 |
| Ghose rule | RDKit | Passed |
| Veber rule | RDKit | Good |
| Egan rule | RDKit | Good |
| GSK 4/400 rule | RDKit | Good |
| Pfizer 3/75 rule | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.65 |
| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Very soluble |
| Solubility class [Silicos-IT] | SwissADME | Soluble |
| Blood Brain Barrier permeation | SwissADME | Yes |
| Gastrointestinal absorption | SwissADME | High |
| Log Kp (Skin permeation, cm/s) | SwissADME | -7.60 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 0 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | No |
| Protein identifier | HGNC symbol | Combined score from STITCH database |
|---|---|---|
| ENSP00000360968 | CYP4X1 | 908 |
| ENSP00000346768 | UGT1A9 | 726 |
| ENSP00000363832 | AOX1 | 909 |
| ENSP00000362508 | UGT1A4 | 908 |
| ENSP00000407546 | CHRNA7 | 700 |
| ENSP00000342007 | CYP1A2 | 728 |
| ENSP00000387683 | UGT2B11 | 900 |
| ENSP00000367959 | HTR2A | 833 |
| ENSP00000361125 | VEGFA | 800 |
| ENSP00000333212 | CYP2U1 | 900 |
| ENSP00000283916 | TMPRSS11D | 786 |
| ENSP00000265403 | UGT2B10 | 919 |
| ENSP00000299565 | CHRNA5 | 718 |
| ENSP00000301141 | CYP2A6 | 975 |
| ENSP00000308032 | CYP2S1 | 900 |
| ENSP00000324648 | CYP2B6 | 794 |
| ENSP00000270202 | AKT1 | 938 |
